CCL20 and colorectal carcinoma: Regarding CCL20, similar to our findings in NPC, its high expression has been confirmed to be associated with poorer prognosis in various cancers, including hepatocellular carcinoma (HCC)34, breast cancer35, colorectal cancer (CRC)36, and pancreatic cancer37.